[Results obtained with L-DOPA and amantadine in the treatment of patients with disorders of consciousness and of the vigilant state].
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D001288:Attention / Q000187:drug effects; D001927:Brain Diseases / Q000150:complications; D001930:Brain Injuries / Q000150:complications; D001932:Brain Neoplasms / Q000150:complications; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D003288:Contusions / Q000150:complications; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005260:Female; D006406:Hematoma / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D012893:Sleep Wake Disorders / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D000547:Amantadine
Risultati ottenuti con il L-DOPA e amantadina nel trattamento di pazienti con turbe della coscienza e dello stato di vigilanza